The left ventricular (LV) ejection fraction (EF) is key to prognosis in dilated cardiomyopathy
(DCM). Circulating microRNAs have emerged as reliable biomarkers for heart diseases …

Background: Circulating microRNAs (miRNAs) potentially carry disease-specific information.
In the current study, we aim to characterize the miRNA signature in plasma from dilated …

Circulating miRNAs are proposed as a biomarker of heart disease. This study evaluated
whether circulating miRNAs could be used as a biomarker for childhood dilated …

Dilated cardiomyopathy (DCM) is a heart muscle disease characterized by ventricular
dilation and systolic dysfunction in the absence of abnormal loading conditions or coronary …

Aim The potential diagnostic utility of circulating microRNAs in heart failure (HF) or in
distinguishing HF with reduced vs. preserved left ventricular ejection fraction (HFREF and …

Aims Heart failure describes a large and heterogeneous spectrum of underlying cardiac
diseases. MicroRNAs (miRs) are small non‐coding RNAs that in recent years have been …

Background MicroRNAs (miRNAs) are non-coding RNAs that function as regulators of gene
expression and thereby contribute to the complex disease phenotypes. Hypertrophic …

Background: In recent years, many microRNAs (miRNAs) were shown to be dysregulated in
specific tissues playing critical roles in the pathogenesis and progression of heart failure …

Background. Left ventricular reverse remodeling (LVRR) determines clinical status and
outcomes in dilated cardiomyopathy (DCM). The extent of myocardial fibrosis is connected …

Abstract Objective We Sought to identify circulating miRNAs suitable for HF diagnosis.
Methods In this study, a genome-wide plasma miRNA microarray was performed in 13 HF …